Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors in the gastrointestinal tract. Recently, many methods for the diagnosis of GIST have been developed including molecular diagnosis. Methods : We selected 90 cases of GIST that had presented at Kyungpook National University Hospital between 1998 and 2007. Tissue microarrays were made using core areas of tumor tissues. Immunohistochemical staining for c-kit, protein kinase C-theta, and platelet-derived growth factor receptor alpha (PDG-FRA) was done. Direct sequencing of hot spot exonal areas for c-kit and PDGFRA were done using extracted DNAs of all 90 paraffin block tissues. Results : Among the 90 cases, 83.3% (75/90) were c-kit positive, 16.6% (15/90) were c-kit negative, 93.3% (84/90) were PDGFRA positive, and 6.6% (6/90) cases were PDGFRA negative. Fifteen cases of c-kit negative GIST included 1 case of PDGFRA negative and 5 cases of PDGFRA negative GIST were ckit positive. The one case in which both c-kit and PDGFRA were negative, showed a c-kit mutation in exon 11. Conclusions : Combined immunohistochemical staining of c-kit, discovered on GIST 1 (DOG1) and PDGFRA is helpful for the diagnosis of GIST. When all staining tests are negative for immunoreactivity, c-kit mutation analysis for exon 11, 9 should be done. Genotyping of kit and PDGFRA do not need to be examined initially, if it is only for the diagnosis of GIST.
. Algorithmic approach to diagnosis of gastrointestinal stromal tumors (GIST). When there is a soft tissue tumor composed of spindle cells around the gastrointestinal tract, it is helpful for the diagnosis of GIST to use c-kit, CD34, S-100, and desmin. If one GIST is c-kit negative, and platelet-derived growth factor receptor alpha (PDGFRA), discovered on GIST 1 (DOG1), and protein kinase C (PKC)-theta are positive on supplemental immunohistochemistry, it should be considered that staining immunoreactivity is generating false positives. If all immunostaining is negative for c-kit, then exon 11, exon 9 mutation analysis is the first step towards diagnosis. Then, genotyping of PDGFRA exon 12, exon 18 is recommended. If the tumor shows mostly fibroblasts on Masson's trichrome staining, it is a fibroblastic tumor. If a tumor shows only S-100 immunoreactivity, it is of Schwann cell origin; if only smooth muscle actin or desmin are positive, it is of muscular origin. 
